Uterine sarcoma treated by cytoreductive surgery and intraperitoneal hyperthermic perfusion: A feasiblity study

Journal of Chemotherapy

Volumn 16, Issue SUPPL. 5, 2004, Pages 19-22

  Kusamura, Shigeki ^a   Raspagliesi, F ^a   Baratti, D ^a   Gronchi, A ^a   Casali, P ^a   Deraco, M ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Peritonectomy and intraperitoneal hyperthermic perfusion; Uterine sarcoma

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOMYCIN C;

ADULT; AGED; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; EVALUATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; MORBIDITY; MORTALITY; PERFUSION; PREOPERATIVE TREATMENT; SAFETY; SIDE EFFECT; TECHNIQUE; TREATMENT OUTCOME; UTERUS SARCOMA;

EID: 11144235196     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1120009x.2004.11782376     Document Type: Conference Paper

References (11)

1. Forney JP, Bushbaum HJ: Classifying, staging, and treating uterine sarcomas. Contemp Ob Gyn 1981; 18(3): 47, 50, 55, 55-56, 61-62, 64, 69.
2. Marchese MJ, Liskow AS, Crum CP, McCaffrey RM, Frick HC, 2nd. Uterine sarcomas: a clinicopathologic study, 1965-1981. Gynecol Oncol 1984; 18:299-312.
3. Hornback NB, Omura G, Major FJ. Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int J Radit Oncol Biol Phys 1986; 12:2127-2130.
4. Livi L, Paiar F, Shah N, et al. Uterine sarcoma: twenty-seven years of experience. Int J Radiat Oncol Biol Phys 2003; 57(5):1366-73.
5. Dinh TA, Oliva EA, Fuller AF Jr, Lee H, Goodman A. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital. Gynecol Oncol 2004;92(2):648-52.
6. Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 2004;11(4):393-8.
7. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21(20):3737-43.
8. Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol 2003;83(3):147-53.
9. Rossi CR, Deraco M, De Simone M, et al. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Cancer 2004;100(9):1943-50.
10. Jacquet P, Sugarbaker PH: Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 1996;15:49-58.
11. Omura GA, Blessing JA, Major F, et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol 1985;3(9):1240-5.